p53 protein expression in benign lesions of the upper respiratory tract

Archives of Otolaryngology - Head and Neck Surgery

Volumn 123, Issue 3, 1997, Pages 297-300

  Ingle, Rajendrakumar R ^a   Setzen, Gavin ^a   Koltai, Peter J ^a   Monte, Denise ^a   Pastore, Joseph ^a   Jennings, Timothy A ^a  

^a ALBANY MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN P53;

ARTICLE; CARCINOGENESIS; CLINICAL ARTICLE; GENE EXPRESSION REGULATION; GROWTH REGULATION; HUMAN; HUMAN TISSUE; LARYNX PAPILLOMATOSIS; NOSE POLYP; PROTEIN SYNTHESIS REGULATION; RESPIRATORY EPITHELIUM; TUMOR SUPPRESSOR GENE;

EID: 0030949803     PISSN: 08864470     EISSN: None     Source Type: Journal    
DOI: 10.1001/archotol.1997.01900030071009     Document Type: Article

References (20)

1. Ogden GR, Kiddie RA, Lunny DP, Lane DP. Assessment of p53 protein expression in normal, benign, and malignant oral mucosa. J Pathol. 1996;166:389-394.
2. Watling DL, Gown AM, Coltrera MD. Overexpression of p53 in head and neck cancer. Head Neck. 1992;14:437-444.
3. Harris CC, Hollistein M. Clinical implications of the p53 tumor-suppressor gene. N Engl J Med. 1993;329:1318-1325.
4. Levine AJ, Momand J, Finaly CA. The p53 tumor suppressor gene. Nature. 1991;351:453-456.
5. Somers KD, Merrick MA, Lopez ME, Incongito LS, Schechter GL, Casey G. Frequent p53 mutations in head and neck cancers. Cancer Res. 1992;52:5997-6000.
6. Lane DP. The regulation of p53 function: Steiner Award Lecture. Int J Cancer. 1994;57:623-627.
7. Soussi T, Legros Y, Lubin R, Dry K, Schlichtholz B. Multifactorial analysis of p53 alteration in human cancer: a review. Int J Cancer. 1994;57:1-9.
8. Mietz JA, Unger T, Huibregtse JM, Howley PM. The transcriptional transactivation function of wild type p53 is inhibited by SV40 large T-antigen and by HPV-16 E6 oncoprotein. EMBO J. 1992;11:5013-5020.
9. Gaylis B, Hayden RE. Recurrent respiratory papillomatosis: progression to invasion and malignancy. Am J Otolaryngol. 1991;12:104-112.
10. Solomon D, Smith RRL, Kashima HK, Leventhal BG. Malignant transformation in non-irradiated recurrent respiratory papillomatosis. Laryngoscope. 1985;95: 900-904.
11. Smith EM, Johnson SR, Cripe TP, Pignatari S, Turek L. Perinatal vertical transmission of human papillomavirus and subsequent development of respiratory tract papillomatosis. Ann Otol Rhinol Laryngol. 1991;100:479-483.
12. Steinberg BM, Meade R, Kalinowski S, Abramson AL. Abnormal differentiation of human papillomavirus-induced laryngeal papillomas. Arch Otolaryngol Head Neck Surg. 1990;116:1167-1171.
13. Steinberg BM. Human papillomaviruses and upper airway oncogenesis. Am J Otolaryngol. 1990;11:370-374.
14. Byrne JC, Tsao MS, Fraser RS, Howley PM. Human papillomavirus-11 DNA in a patient with chronic laryngotracheobronchial papillomatasis and metastatic squamous-cell carcinoma of the lung. N Engl J Med. 1987;317:873-878.
15. Keim RJ. Malignant change of laryngeal papillomas: a case report. Otolaryngol Head Neck Surg. 1980;88:773-777.
16. Quick CA, Foucar E, Dehner LP. Frequency and singificance of epithelial atypia in laryngeal papillomatosis. Laryngoscope. 1979;89:550-560.
17. Boyle JO, Hakim J, Koch W, et al. The incidence of p53 mutations increases with progression of head and neck cancer. Cancer Res. 1993;53:4477-4480.
18. Clark LJ, MacKenzie K, Parkinson EK. Elevated levels of the p53 tumor suppressor protein in the basal layer of recurrent laryngeal papillomas. Clin Otolaryngol. 1993;18:63-65.
19. Linden MD, Nathanson SD, Zarbo RJ. Evaluation of anti-p53 antibody staining: quality control and technical considerations. Appl Immunohistochem. 1994; 2:218-224.
20. Fouret P, Dabit D, Sibony M, et al. Expression of p53 protein related to the presence of human papillomavirus infection in precancer lesions of the larynx. Am J Pathol. 1995;146:599-604.